Scarica l'app Stockscreener
0.8082
2.63%
-0.0218
Pre-mercato:
.84
0.0318
+3.93%
Precedente Chiudi:
$0.83
Aprire:
$0.8334
Volume 24 ore:
225.74K
Relative Volume:
0.34
Capitalizzazione di mercato:
$5.08M
Reddito:
$5.66M
Utile/perdita netta:
$-15.88M
Rapporto P/E:
-0.0714
EPS:
-11.3134
Flusso di cassa netto:
$-10.93M
1 W Prestazione:
+0.57%
1M Prestazione:
-53.28%
6M Prestazione:
-37.35%
1 anno Prestazione:
-90.11%
Intervallo 1D:
$0.7823
$0.8343
Intervallo di 1 settimana:
$0.7823
$0.87
Portata 52W:
$0.693
$13.50
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Nome
Bioaffinity Technologies Inc
Settore
Industria
Telefono
210-698-5334
Indirizzo
3300 NACOGDOCHES ROAD, SAN ANTONIO
Compare BIAF vs TMO, DHR, IDXX, NTRA, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
0.8082 | 5.10M | 5.66M | -15.88M | -10.93M | -11.31 |
TMO
Thermo Fisher Scientific Inc
|
517.60 | 186.32B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
193.62 | 134.82B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
564.98 | 41.53B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
283.80 | 38.88B | 2.50B | -226.32M | 71.51M | -1.6412 |
WAT
Waters Corp
|
378.89 | 36.82B | 3.77B | 449.25M | 240.68M | 7.8556 |
Bioaffinity Technologies Inc Borsa (BIAF) Ultime notizie
bioAffinity Technologies Sees Record CyPath® Lung Test Sales, Expands Veteran Screening with Philips Partnership - Minichart
bioAffinity Technologies reports accelerated CyPath Lung sales, Philips partnership to boost veteran screening - TradingView
CyPath Lung sales surge as bioAffinity (NASDAQ: BIAF) expands pipeline - Stock Titan
bioAffinity Technologies Company Profile & Introduction - Moomoo
BIAF Stock Gains As CyPath Sales Surge 146% In Q1 - Stocktwits
bioAffinity Technologies Inc (BIAF) Valuation: PE, PB & Fair Value Analysis - TradingKey
bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells - BioSpace
bioAffinity Technologies reports skin cancer siRNA preclinical results - grafa.com
bioAffinity to present skin cancer treatment research - Investing.com
bioAffinity to present skin cancer treatment research By Investing.com - Investing.com South Africa
BIOAFFINITY TECHNOLOGIES INC (BIAF) Stock Chart - ChartMill
BioAffinity Technologies Closes $3.2 Million Public Offering - Moomoo
bioAffinity Technologies Raises $3.2M in Best-Efforts Offering, Signs Purchase and Placement Pacts - TradingView
bioAffinity Technologies Inc (BIAFW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
bioAffinity Technologies (NASDAQ: BIAF) raises $3.2M in stock and pre-funded warrant sale - Stock Titan
bioAffinity Technologies Announces Closing of $3.2 Million Offering - Quantisnow
WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering - PR Newswire
bioAffinity Technologies closes $3.2M public offering By Investing.com - Investing.com Nigeria
bioAffinity Technologies closes $3.2M public offering - Investing.com
BIOAFFINITY TECHNOLOGIES ANNOUNCES CLOSING OF $3.2 MILLION OFFERING - Moomoo
bioAffinity Technologies Inc (BIAFW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
bioAffinity Technologies Inc (BIAFW) Institutional Confidence - TradingKey
bioAffinity Technologies Inc (BIAFW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
bioAffinity Technologies Inc (BIAFW) Valuation: PE, PB & Fair Value Analysis - TradingKey
bioAffinity (NASDAQ: BIAF) to sell 1.04M shares, up to 2.96M pre-funded warrants - Stock Titan
bioAffinity Technologies Inc (BIAF) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
bioAffinity Technologies Inc (BIAF) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
bioAffinity Technologies Inc (BIAF) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
bioAffinity Technologies Inc (BIAF) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BioAffinity Technologies Prices $3.2 Million Offering; Shares Drop 13% - Moomoo
bioAffinity Technologies (BIAF) Slides Nearly 12% – Testing Key Support at $0.79Impulse Wave - newsline.com
bioAffinity Technologies Inc (BIAF) Institutional Confidence - TradingKey
bioAffinity Technologies Inc (BIAF) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
bioAffinity Technologies Inc (BIAF) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
bioAffinity Technologies Inc (BIAF) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
bioAffinity Technologies prices $3.2M public offering By Investing.com - Investing.com India
bioAffinity Technologies prices $3.2M public offering - Investing.com UK
WallachBeth Capital Announces Pricing of bioAffinity Technologie - GuruFocus
bioAffinity Technologies closes $3.2 million public offering - scanx.trade
WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offering - PR Newswire
bioAffinity Technologies Announces Pricing of $3.2 Million Offering - Business Wire
bioAffinity Technologies Inc (BIAFW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
bioAffinity Technologies Inc (BIAFW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
bioAffinity Technologies Inc (BIAFW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
[EFFECT] bioAffinity Technologies, Inc. SEC Filing - Stock Titan
bioAffinity (BIAF) S-1/A adds placement agency pact and warrant forms - Stock Titan
bioAffinity to participate in veterans lung health webinar By Investing.com - Investing.com Australia
bioAffinity to participate in veterans lung health webinar - Investing.com
bioAffinity Technologies to host July 21 webinar on veteran lung screening with Philips and 4DMedical - TradingView
Veteran lung health webinar from bioAffinity (BIAF) spotlights CyPath® Lung - Stock Titan
Bioaffinity Technologies Inc Azioni (BIAF) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.05%
2.99%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):